Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program

E. Kneppers, H.M. Lokhorst, C.M. Eeltink, G. Huls, M.J. Kersten, J. Koedam, M.C. Minnema, M.H.J. van Oers, R.A.P. Raymakers, M.R. Schaafsma, E. Vellenga, P.W. Wijermans, S. Wittebol, P. Sonneveld, S. Zweegman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)138-143
JournalClinical Lymphoma Myeloma and Leukemia
Issue number2
Publication statusPublished - 2010

Cite this